Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
The United States Solicitor General files an amicus brief effectively siding with Medtronic, arguing that Boston Scientific bears the burden of proof in a long-running patent infringement beef that’s headed for the Supreme Court. Medical device giant Medtronic (NYSE:MDT) may have a little muscle on its side after the U.S. Solicitor General effectively backed the company in long-running patent infringement battle against Boston Scientific (NYSE:BSX) that’s set to hit the Supreme Court later this year.
Help employers find you! Check out all the jobs and post your resume.
